James Feng is a Partner on MSA’s healthcare team, focusing on investments in next-generation biotechnology and life sciences businesses. He has 15 years of medical research and management experience in the healthcare industry, and 11 years of experience in healthcare investments. Previously, he was Executive Director at YuanBio Venture, an early-stage healthcare investment firm. Prior to that, he was the COO of Hopstem Biotechnology. James holds a M.Sc. in bioinformatics from New York University and a BA in molecular biology from Nankai University.
Access investment thesis, focus areas, bio, and contact details for James Feng and 22,000+ other VC professionals.